Clinical Trial Update: Dynamic Annuloplasty System With Activation for the Treatment of Mitral Regurgitation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MiCardia's Dynamic Annuloplasty System With Activation in mitral valve regurgitation. The trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Regurgitation

Drugs mentioned

• Dynamic Annuloplasty System With Activation

Snippet

Sponsor: MiCardia Corporation | Conditions: Mitral Valve Regurgitation | Phase 2 | Status: UNKNOWN